Ben Affleck's Argo is two-two-TWO movies in one, and while neither is especially original, by merging them Affleck pulls off a coup. First, he gives you espionage with the You Are There zing of a documentary. Then he serves up broad showbiz satire. For his final feat, he blends the two into a pulse-pounding nail-biter of a climax. And this all really happened. Most of it. Except for that climax.
"U.S. consumer sentiment unexpectedly rose to its highest in five years in October as consumers became more optimistic about the economy in a possible boost to President Obama's reelection hopes," Reuters reports.
This is TELL ME MORE from NPR News. I'm Celeste Headlee. Michel Martin is away. Coming up, President Obama honored late labor and civil rights leader Cesar Chavez earlier this week but a new book questions whether the full story of his life and legacy isn't perhaps more complicated. That's in a moment.
This morning, the Norwegian Nobel Committee announced the winner of the 2012 Nobel Peace Prize and they chose the European Union.
THORBJORN JAGLAND: The European Union is currently undergoing grave economic difficulties and (unintelligible) social unrest. The Norwegian Nobel Committee wishes to focus on what it sees as the EU's most important result, the successful struggle for peace and reconciliation and for democracy and human rights.
More states and cities are turning to casinos to generate revenue and plug budget holes.
The latest to try its luck is Maryland, where groups are waging an expensive campaign over a ballot question that will be put to voters next month. Proponents promise jackpots of jobs and funding for public schools, but analysts say the gamble doesn't always pay off at the levels promised for public coffers.
This interview was originally broadcast on Oct. 11, 2011. The Viral Storm will be published in paperback on Oct. 16.
The New Yorker once called virologist Nathan Wolfe "the world's most prominent virus hunter." Wolfe, the director of the Global Viral Forecasting Initiative, spends his days tracking emerging infectious diseases before they turn into deadly pandemics.